Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. …
Industry Peers
Medical Distribution| Headline | Source | Time |
|---|---|---|
Yesterday | ||
RRÖDL | ||
This week | ||
Older | ||
PPharmazeutische Zeitung | ||
Aapotheke adhoc | ||
AAriva | ||
PPRReport | ||
PPharmazeutische Zeitung | ||
Aapotheke adhoc | ||
 Private companies account for 35% of Medios AG's (ETR:ILM1) ownership, while institutions account for 26% Key Insights Significant control over Medios by private companies implies that the general public has more power to... | ||
Are Investors Undervaluing Medios AG (ETR:ILM1) By 46%? Key Insights Medios' estimated fair value is €28.73 based on 2 Stage Free Cash Flow to Equity Current share price of... | ||
What Does Medios AG's (ETR:ILM1) Share Price Indicate? Medios AG ( ETR:ILM1 ), is not the largest company out there, but it saw a double-digit share price rise of over 10% in... | ||
Medios' (ETR:ILM1) Earnings May Just Be The Starting Point When companies post strong earnings, the stock generally performs well, just like Medios AG's ( ETR:ILM1 ) stock has... | ||
Is Now The Time To Put Medios (ETR:ILM1) On Your Watchlist? The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even... | ||
Medios (ETR:ILM1) investors are sitting on a loss of 56% if they invested five years ago We think intelligent long term investing is the way to go. But along the way some stocks are going to perform badly. To... | ||